Policy Implications of Pharmaceutical Importation for U.S. Consumers - U.S. Senate Committee on Commerce, Science, & Transportation

Policy Implications of Pharmaceutical Importation for U.S. Consumers

Full Committee Hearing

Date: Wednesday, March 7, 2007

Time: 9:30 AM

Location: SR

Committee Members

Byron L. Dorgan

Senator

Testimony

Randall Lutter

Acting Deputy Commissioner for Policy

Food and Drug Administration

Witness Panel 2

Nelda Barnett

Member, Board of Directors

AARP

Download document
William Schultz

Partner

Zuckerman Spaeder LLP
Stephen Schondelmeyer

Professor and Head, Department of Pharmaceutical Care & Health Systems

University of Minnesota, College of Pharmacy
John Vernon

Assistant Professor, Department of Finance

University of Connecticut School of Business
Billy Tauzin

CEO

PhRMA

Download document